Antara Capital LP — 13F Holdings & Portfolio

CIK 1750183 · latest 13F-HR filed 2026-02-17

Antara Capital LP manages $30.2K in 13F-reported U.S. long-equity assets across 2 reported positions as of its 2025-12-31 13F-HR filing. Its largest disclosed positions are ASBPW (88.65%), ASBPW (11.35%). Quarter over quarter (versus its 2025-09-30 filing) the fund opened 0 new positions, exited 1, added to 0, and trimmed 2.

AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.

Loading holdings…
AUM

$30.2K

Long-equity book

Holdings

2

Distinct positions

Period

2025-12-31

Filed 2026-02-17

Q/Q Activity

+0 / −1 / ↑0 / ↓2

vs 2025-09-30

Firm Profile & Key People
Name Title / Status Ownership Type

Top Adds (vs prior quarter)

  • No increased positions.
Show all 0

Top Trims

  • ASPIRE BIOPHARMA HLDGS INC-$15.0K -36.0%
  • ASPIRE BIOPHARMA HLDGS INC-$2.8K -44.8%
Show all 2

New Positions

  • No new positions this quarter.
Show all 0

Exited Positions

  • CURRENC GROUP INC$442.2K
Show all 1
All Holdings

Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).

# Issuer Symbol CUSIP Value Weight Shares Type
1 ASPIRE BIOPHARMA HLDGS INC ASBPW 738920107 $26.8K 88.65% 202,897 SH
2 ASPIRE BIOPHARMA HLDGS INC ASBPW 738920115 $3.4K 11.35% 207,693 SH
Filing History
Period Filed AUM Holdings Accession
2025-12-31 2026-02-17 $30.2K 2 0001172661-26-001155
2025-09-30 2025-11-14 $490.2K 3 0001750183-25-000016